The U.S. Food and Drug Administration approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis.
Read More
(Source: salutedomani.com)
Posted 1 year ago
7 notes
Tags: Myelofibrosis, fda, jakafi, ruxolitinib, blood, cells, enzymes, symptoms, platelets, cancer, donor, thrombocytopenia, nausea, headache, dyspnea, dizzness, diarrhea, anemia,